Format
Items per page
Sort by

Send to:

Choose Destination

Links from

Items: 1 to 20 of 143

1.

Cost of nonmelanoma skin cancer treatment in the United States.

Chen JG, Fleischer AB Jr, Smith ED, Kancler C, Goldman ND, Williford PM, Feldman SR.

Dermatol Surg. 2001 Dec;27(12):1035-8.

PMID:
11849266
2.

Nonmelanoma skin cancer: an episode of care management approach.

Housman TS, Williford PM, Feldman SR, Teuschler HV, Fleischer AB Jr, Goldman ND, Balkrishnan R, Chen GJ.

Dermatol Surg. 2003 Jul;29(7):700-11.

PMID:
12828693
3.

Skin cancer is among the most costly of all cancers to treat for the Medicare population.

Housman TS, Feldman SR, Williford PM, Fleischer AB Jr, Goldman ND, Acostamadiedo JM, Chen GJ.

J Am Acad Dermatol. 2003 Mar;48(3):425-9.

PMID:
12637924
4.

Treatment patterns and cost of nonmelanoma skin cancer management.

John Chen G, Yelverton CB, Polisetty SS, Housman TS, Williford PM, Teuschler HV, Feldman SR.

Dermatol Surg. 2006 Oct;32(10):1266-71.

PMID:
17034377
5.
6.

Mohs micrographic surgery vs traditional surgical excision: a cost comparison analysis.

Bialy TL, Whalen J, Veledar E, Lafreniere D, Spiro J, Chartier T, Chen SC.

Arch Dermatol. 2004 Jun;140(6):736-42.

PMID:
15210467
7.

Cost effectiveness of Mohs micrographic surgery: review of the literature.

Tierney EP, Hanke CW.

J Drugs Dermatol. 2009 Oct;8(10):914-22. Review.

PMID:
19852120
8.

The economic impact of non-melanoma skin cancer: a review.

Mudigonda T, Pearce DJ, Yentzer BA, Williford P, Feldman SR.

J Natl Compr Canc Netw. 2010 Aug;8(8):888-96. Review.

PMID:
20870635
9.

Incidence estimate of nonmelanoma skin cancer in the United States, 2006.

Rogers HW, Weinstock MA, Harris AR, Hinckley MR, Feldman SR, Fleischer AB, Coldiron BM.

Arch Dermatol. 2010 Mar;146(3):283-7. doi: 10.1001/archdermatol.2010.19.

PMID:
20231499
10.
11.

Surgical treatment of nonmelanoma skin cancer in the Medicare population.

Manternach T, Housman TS, Williford PM, Teuschler H, Fleischer AB Jr, Feldman SR, Chen GJ.

Dermatol Surg. 2003 Dec;29(12):1167-9; discussion 1169.

PMID:
14725656
12.

National Ambulatory Medical Care Survey: 2001 summary.

Cherry DK, Burt CW, Woodwell DA.

Adv Data. 2003 Aug 11;(337):1-44.

PMID:
12924075
13.
14.

How many nonmelanoma skin cancers require Mohs micrographic surgery?

Welch ML, Anderson LL, Grabski WJ.

Dermatol Surg. 1996 Aug;22(8):711-3.

PMID:
8780764
15.

No end in sight: the skin cancer epidemic continues.

Donaldson MR, Coldiron BM.

Semin Cutan Med Surg. 2011 Mar;30(1):3-5. doi: 10.1016/j.sder.2011.01.002.

PMID:
21540015
17.

Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012.

Rogers HW, Weinstock MA, Feldman SR, Coldiron BM.

JAMA Dermatol. 2015 Oct;151(10):1081-6. doi: 10.1001/jamadermatol.2015.1187.

PMID:
25928283
18.

[Cost per episode of care in the surgical treatment of skin cancer].

Hernández Martín A, Núñez Reiz A, Sáiz Martínez M, Rovirosa i Juncosa J.

Gac Sanit. 2006 Jul-Aug;20(4):273-9. Spanish.

19.

Epidemiology and economic burden of nonmelanoma skin cancer.

Cakir BÖ, Adamson P, Cingi C.

Facial Plast Surg Clin North Am. 2012 Nov;20(4):419-22. doi: 10.1016/j.fsc.2012.07.004. Review.

PMID:
23084294
20.

Nonmelanoma skin cancer mortality (1988-2000): the Rhode Island follow-back study.

Lewis KG, Weinstock MA.

Arch Dermatol. 2004 Jul;140(7):837-42.

PMID:
15262694
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk